Recombinant human bone morphogenetic protein-2 released from polyurethane-based scaffolds promotes early osteogenic differentiation of human mesenchymal stem cells

The purposes of this study were to determine the pharmacokinetics of recombinant human bone morphogenetic protein-2 (rhBMP-2) from a polyurethane (PUR)-based porous scaffold and to determine the biological responses of human mesenchymal stem cells (hMSCs) to the rhBMP-2 released from those scaffolds. The rhBMP-2 was incorporated into the PUR three-dimensional (3D) porous scaffolds and release profiles were determined using enzyme-linked immunosorbent assay. The bioactivity of the rhBMP-2 containing releasates was determined using hMSCs and compared with exogenous rhBMP-2. Release of rhBMP-2 from PUR-based systems was bi-phasic and characterized by an initial burst followed by a sustained release for up to 21 days. Expression of alkaline phosphatase activity by hMSCs treated with the rhBMP-2 releasates was significantly greater than the cells alone (control) throughout the time periods. Furthermore, after 14 days of culture, the hMSCs cultured with rhBMP-2 releasate had a greater amount of mineralization compared to exogenous rhBMP-2. Overall, the rhBMP-2 release from the PUR-based scaffolds was sustained for 21 days and the releasates appeared to be bioactive and promoted earlier osteogenic differentiation and mineralization of hMSCs than the exogenous rhBMP-2.

[1]  Bradley K Weiner,et al.  A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. , 2011, The spine journal : official journal of the North American Spine Society.

[2]  T. Guda,et al.  Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. , 2011, Tissue engineering. Part A.

[3]  R. Tuan,et al.  Cell delivery therapeutics for musculoskeletal regeneration. , 2010, Advanced drug delivery reviews.

[4]  J. Nyman,et al.  The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora. , 2009, Biomaterials.

[5]  S. Bellis,et al.  Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrix. , 2009, Biomacromolecules.

[6]  T. Hefferan,et al.  Potential of hydrogels based on poly(ethylene glycol) and sebacic acid as orthopedic tissue engineering scaffolds. , 2009, Tissue engineering. Part A.

[7]  Jonathan E. Didier,et al.  Synthesis, mechanical properties, biocompatibility, and biodegradation of polyurethane networks from lysine polyisocyanates. , 2008, Biomaterials.

[8]  M. Casal,et al.  Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery) , 2008, Journal of tissue engineering and regenerative medicine.

[9]  Paolo Giannoni,et al.  A tissue engineering approach to bone repair in large animal models and in clinical practice. , 2007, Biomaterials.

[10]  S. Guelcher,et al.  Synthesis, in vitro degradation, and mechanical properties of two-component poly(ester urethane)urea scaffolds: effects of water and polyol composition. , 2007, Tissue engineering.

[11]  C. V. van Blitterswijk,et al.  The response of human mesenchymal stem cells to osteogenic signals and its impact on bone tissue engineering. , 2007, Current stem cell research & therapy.

[12]  J. Guan,et al.  Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Byung-Soo Kim,et al.  Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. , 2007, Biomaterials.

[14]  Clemens A van Blitterswijk,et al.  Cell-Based Bone Tissue Engineering , 2007, PLoS medicine.

[15]  A. Osyczka,et al.  Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. , 2005, Endocrinology.

[16]  H. Seeherman,et al.  Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. , 2005, Cytokine & growth factor reviews.

[17]  Antonios G Mikos,et al.  Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-glycerol phosphate. , 2005, Biomaterials.

[18]  Antonios G Mikos,et al.  Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. , 2003, Journal of biomedical materials research. Part A.

[19]  Ralph Müller,et al.  Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.

[20]  Linshu Liu,et al.  Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2). , 2002, Journal of biomedical materials research.

[21]  Allan S Hoffman,et al.  Hydrogels for biomedical applications. , 2002, Advanced drug delivery reviews.

[22]  D H Kohn,et al.  Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. , 2000, Biomaterials.

[23]  J. Davies,et al.  Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: investigating initial cell-seeding density and culture period. , 2000, Journal of biomedical materials research.

[24]  V. Goldberg,et al.  Hyaluronic acid‐based polymers as cell carriers for tissue‐engineered repair of bone and cartilage , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[25]  J. Wozney,et al.  Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. , 1998, Journal of biomedical materials research.

[26]  J. Wozney,et al.  Effects of recombinant human bone morphogenetic protein-2 on differentiation of cells isolated from human bone, muscle, and skin. , 1998, Bone.

[27]  V. Rosen,et al.  Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. , 1992, Endocrinology.

[28]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[29]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[30]  Kinam Park,et al.  Control of encapsulation efficiency and initial burst in polymeric microparticle systems , 2004, Archives of pharmacal research.

[31]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[32]  Su‐Li Cheng,et al.  Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. , 1994, Endocrinology.